From February 6, 2024 to March 31, 2024, the company has repurchased 4,119,486 shares, representing 5.13% for $11.04 million. With this, the company has completed the repurchase of 4,119,486 shares, representing 5.13% for $11.04 million under the buyback announced on March 1, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.93 USD | +0.52% |
|
-10.23% | -12.67% |
05-20 | Standard BioTools Receives Shareholder Proposal from Madryn Asset Management | CI |
05-08 | Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on March 1, 2024. | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.67% | 714M | |
+6.37% | 216B | |
+10.21% | 189B | |
+28.22% | 153B | |
+34.42% | 114B | |
+0.80% | 63.2B | |
+19.21% | 54.78B | |
+0.13% | 48.47B | |
-4.16% | 38.88B | |
+2.39% | 36.14B |
- Stock Market
- Equities
- LAB Stock
- News Standard BioTools Inc.
- Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on March 1, 2024.